<DOC>
	<DOCNO>NCT01347112</DOCNO>
	<brief_summary>Alcohol dependence significant prevalent public health problem affect approximately 4 % U.S. adult population . Individuals alcohol dependence actively seek treatment annually , long-term alcohol abstinence vary 40-60 % . Because high smoking prevalence trend toward heavy smoking , alcoholic smoker high risk morbidity mortality relate alcohol consumption tobacco dependence . Although several study evaluate pharmacotherapy tobacco dependence recover alcoholic smoker , evaluate pharmacotherapy tobacco dependence among currently drink alcoholic smoker . Varenicline effective medication currently available treat tobacco dependence . While randomized trial include recover alcoholic , active alcoholism exclusion criterion trial . Thus , proposal would first clinical trial currently drink alcoholic smoker . In addition help smoker stop smoking , varenicline also show reduce alcohol consumption rat . The goal proposal explore potential efficacy varenicline treat tobacco dependence reduce drinking among alcohol dependent smoker . The investigator hypothesize 12 week treatment varenicline , partial nicotinic acetylcholine receptor agonist effective placebo treat tobacco dependence reduce nicotine withdrawal symptom currently drink alcoholic smoker . The investigator also explore whether varenicline effect drink behavior among currently drink alcoholic . The investigator propose follow specific aim test hypothesis 70 currently drink alcoholic smoker recruit Mayo Clinic Rochester , Minnesota .</brief_summary>
	<brief_title>Varenicline Treatment Active Alcoholic Smokers</brief_title>
	<detailed_description>Seventy smoker currently alcohol dependent enrol study . If find study eligible randomize either active varenicline placebo 12 week . During two week , see either weekly biweekly . At end treatment , follow addition 12 week . Their last study visit 6 month randomization .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>1 . Male nonpregnant female cigarette smoker 18yearsofage old reporting smoking least average 10 cigarette per day past year ; 2 . Subject alcohol dependence base DSM IV criterion assess MiniInternational Neuropsychiatric Interview ( MINI ) physician investigator ; 3 3 . Subject currently drink alcoholic beverage assess physician investigator ; 4 . Subject female subject nonchildbearing potential female subject childbearing potential use contraceptive negative pregnancy test result ; 5 . Subject must able complete study visit ; 6 . Subject ability participate fully aspects study keep scheduled appointment ; 7 . Subject must good general health determine medical history , physical exam physician investigator ; 8 . Subject must provide write informed consent participate study ; 1 . Subject female pregnant , lactate likely become pregnant trial willing use acceptable form contraception medication phase , ( woman childbearing potential , pregnancy test perform prior entry study end medication phase ) ; 2 . Subject another household member study ; 3 . Known allergy varenicline ; 4 . Subject currently ( previous 30 day ) use behavioral pharmacologic tobacco cessation program ( i.e. , behavioral therapy , nicotine replacement therapy , clonidine , varenicline , bupropion SR , nortriptyline doxepin ) unwilling unable discontinue use ; 5 . Subject unstable medical condition determine physician investigator ; 6 . Subject describes medical history : ) unstable angina ; b ) myocardial infarction within past 3 month ; c ) coronary angioplasty ) untreated cardiac dysrhythmia ; 7 . Subject personal history renal failure renal dialysis ; 8 . Subject current moderate severe depression assess Center Epidemiologic StudiesDepression survey ( CESD ) physician investigator ; 9 . Subject , define Columbia Suicide Severity Rating Scale ( CSSRS ) current nonspecific suicidal thought , lifetime history suicidal attempt ( define `` potentially selfinjurious act commit least wish die , result act '' ) ; 10 . Subject current ( past 30 day ) major depressive disorder history another psychiatric disorder psychosis bipolar disorder ; 11 . Subject currently use tobacco product ( i.e . pipe , cigar , smokeless tobacco ) within past 30 day ; 12 . Subject currently cancer [ exclude non melanoma skin cancer ] remission ( cancer free 5 year ) ; 13 . Subject currently Type 1 diabetes ; 14 . Subject untreated hypertension baseline systolic blood pressure &gt; 180 diastolic &gt; 100 ; 15 . Subject currently treatment another investigational drug ( within 30 day study entry ) ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>smoking</keyword>
	<keyword>tobacco dependence</keyword>
	<keyword>alcohol dependence</keyword>
</DOC>